Cornerstone Financial Management
MENS icon

Cornerstone Financial Management’s Jyong Biotech MENS Stock Holding History

Cornerstone Financial Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$480 Hold
234
– – ﹤0.01% 1447
2026
Q2 		$484 Buy
+234
New +$496 ﹤0.01% 1406
2026
Q1 		– Sell
-14
Closed -$55 – 1400
2025
Q4 		$55 Buy
+14
New +$494 ﹤0.01% 1236

Other funds holding MENS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bell Investment Advisors
Bell Investment Advisors Oakland, California $684M AUM 11.43% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Cornerstone Financial Management's MENS Position: Q3 2026 in Review

Cornerstone Financial Management held its Jyong Biotech (MENS) position steady in Q3 2026 at 234 shares worth $480. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Cornerstone Financial Management first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $484 in Q2 2026. 11 funds tracked by Wall St. Rank hold MENS as of Q3 2026.

  • Cornerstone Financial Management held 234 shares of Jyong Biotech worth $480 as of Q3 2026.
  • Cornerstone Financial Management left its Jyong Biotech share count unchanged in Q3 2026.
  • Jyong Biotech made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q3 2026, its #1447 holding.
  • Cornerstone Financial Management first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's Jyong Biotech position peaked at $484 in Q2 2026.
  • 11 funds tracked by Wall St. Rank held Jyong Biotech as of Q3 2026.

Based on Cornerstone Financial Management's 13F filing for Q3 2026, filed 10 Nov 2026.